Photo for representation only.
New Delhi, October 25
Pointing out that over 100 crore doses of Covishield had been supplied in India and many other countries, the Serum Institute of India on Monday sought regular marketing approval for the Covid vaccine, currently authorised for emergency use in the country, official sources said.
The application sent to the Drugs Controller General of India (DCGI) by Prakash Kumar Singh, Director, Government and Regulatory Affairs, SII, comes just a couple of days after PM Narendra Modi held a meeting with domestic Covid-19 vaccine manufacturers.
If the DCGI grants regular marketing authorisation, Covishied will be the second vaccine in the world to receive such approval. Pfizer-BioNTech's Covid-19 vaccine has received full US FDA approval for use in individuals 16 years of age and older. — PTI
Join Whatsapp Channel of The Tribune for latest updates.
Most Read In 24 Hours
Don't Miss
View All
Top News
Deeply biased: MEA on US report citing human rights violations in India
The annual report of the State Department highlights instanc...
Couldn't talk due to strictness of jail authorities: Amritpal's family after meeting him in jail
Their visit comes a day after Singh's legal counsel Rajdev S...
Centre grants 'Y' category security to Phillaur MLA Vikramjit Chaudhary and 2 other Punjab Congress rebels
The Central Reserve Police Force has been directed by the Mi...
First Sikh court opens in UK to deal with family disputes
According to ‘The Times’, the Sikh court was launched last w...
